Biology Reference
In-Depth Information
122. Bengtsson BO, Zhu J, Thorell LH, Olsson T, Link H, Walinder J. Effects of zimelidine
and its metabolites, clomipramine, imipramine and maprotiline in experimental allergic
neuritis in Lewis rats. J Neuroimmunol 1992;39:109-22.
123. Zhu J, Bengtsson BO, Mix E, Thorell LH, Olsson T, Link H. Effect of monoamine
reuptake inhibiting antidepressants on major histocompatibility complex expression
on macrophages in normal rats and rats with experimental allergic neuritis (EAN).
Immunopharmacology 1994;27:225-44.
124. Kubera M, Kenis G, Bosmans E, Kajta M, Basta-Kaim A, Scharpe S, et al. Stimulatory
effect of antidepressants on the production of IL-6. Int Immunopharmacol 2004;4:185-92.
125. Calapai G, Crup A, Firenzuoli F, Inferrera G, Ciliberto G. Interleukin-6 involvement in
antidepressant action of
Hypericum perforatum
. Pharmacopsychiatry 2001;34:58-60.
126. Anisman H, Merali Z. Cytokines, stress and depressive illness. Brain Behav Immun
2002;16:513-24.
127. Fessel W, Hirata-Hibi M. Abnormal leukocytes in schizophrenia. Arch Gen Psychiatry
1963;74:129-40.
128. Heath RG, Krupp IM. Schizophrenia as an immunologic disorder. I. Demonstration of anti-
brain globulin by fluorescent antibody techniques. Arch Gen Psychiatry 1967;39:82-87.
129. Pandey RS, Gupta AK, Chaturvedi JC. Autoimmune model of schizophrenia with special
reference to antibrain antibodies. Biol Psychiatry 1981;16:1123-36.
130. Ganguli R, Rabin BS, Kelly RH, Lute M, Ragu U. Clinical and laboratory evidence of
autoimmunity in acute schizophrenia. Ann NY Acad Sci 1987;496:676-85.
131. Carlsson A, Lindquist M. Effect of chlorpromazine and haloperidol on the formation
of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol
(Copenh) 1963;20:140-44.
132. Knight JG. Dopamine receptor stimulating autoantibodies, a possible cause of schizo-
phrenia. Lancet 1982;i:1073-76.
133. Korschenhausen D, Hampel H, Ackenheil M, Penning R, Mullen N. Fibrin degradation
products in post mortem brain tissue of schizophrenics: a possible marker for underlying
inflammatory processes. Schizophr Res 1996;9:103-9.
134. Cazzullo CL, Scarone S, Grassi B, Vismara C, Trabattoni D, Clerici M. Cytokines pro-
duction in chronic schizophrenia patients with or without paranoid behaviour. Prog
Neuropsychopharmacol Biol Psychiatry 1998;22:947-57.
135. Muller N, Ackenheil M. Psychoneuroimmunology and cytokine action in the CNS:
implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry
1995;19:65-74.
136. Korte S, Arolt V, Peters M, Weitzsch C, Eckhoff D, Rothermundt M, et al. Increased
serum neopterin levels in acutely ill and recovered schizophrenic patients. Schizophr Res
1998;32:63-67.
137. Sperner-Unterweger B, Barnas C, Fuchs D, Kemmler G, Wachter H, Hinterhuber H,
et al. Neopterin production in acute schizophrenic patients: an indicator of alterations in
cell mediated immunity. Psychiatry Res 1992;42:121-28.
138. Masserini C, Vita A, Basile R, Morselli R, Boato P, Peruzzi C, et al. Lymphocyte subsets
in schizophrenic disorders: relationship with clinical, neuromorphological and treatment
variables. Schizophr Res 1990;3:269-75.
139. Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. Interleukin-2 and interleukin-6
in schizophrenia and mania: effects of neuroleptics and mood stabilisers. J Psychiatr Res
1995;29:141-52.
140. Pollmacher T, Hinze-Selch D, Mullington J, Holsboer F. Clozapine-induced increase in
plasma levels of soluble interleukin-2 receptors. Arch Gen Psychiatry 1995;52:877-78.
